Literature DB >> 30205195

A cross-sectional analysis of Zika virus infection in symptomatic and asymptomatic non-pregnant travellers: Experience of a European reference center during the outbreak in the Americas.

Ralph Huits1, Ula Maniewski2, Dorien Van Den Bossche2, Erica Lotgering2, Achilleas Tsoumanis2, Lieselotte Cnops2, Jan Jacobs3, Marjan Van Esbroeck2, Emmanuel Bottieau2.   

Abstract

BACKGROUND: Zika virus (ZIKV) infection a concern to travellers because of potential sexual transmission and adverse pregnancy outcomes.
OBJECTIVE: To describe our experience in diagnosing ZIKV in travellers returning from endemic territories.
METHOD: Travellers were evaluated for ZIKV at our clinic in a 12-month period during the outbreak, using ZIKV-specific RT-PCR and anti-ZIKV Immunoglobulin M/G ELISA when symptomatic, and ELISA only for asymptomatic travellers, preferably from 20 days after the last exposure. All positive ELISA results were subject to confirmation by Virus Neutralization Testing. We estimated post-test probabilities of ZIKV in asymptomatic travellers.
RESULTS: Of 462 travellers, 227 reported symptoms and 235 did not. Asymptomatic travellers had similar baseline characteristics, but were younger (median age 31 vs. 33 years, p = 0.01) and had reproductive concerns more often (75.8% vs. 24.2%). ZIKV infection was confirmed in 49 cases: 46/227 (20.3%) were symptomatic and 3/235 (1.3%) asymptomatic. Rash (positive likelihood ratio (LRP) 5.6) and conjunctivitis (LRP 10.8) predicted ZIKV infection. The post-test probability of a negative ELISA-result at 20-25 days was below 0.1%.
CONCLUSION: ZIKV infection was frequent in symptomatic, but not in asymptomatic travellers. We consider negative ELISA results at 20-25 days after exposure a safe strategy to rule out ZIKV infection. Testing for ZIKV-specific antibodies within this timeframe could be particularly valuable in the management of returning travellers who wish to conceive.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Asymptomatic; ELISA; Likelihood ratio; Outbreak; Returning traveller; Zika virus

Mesh:

Substances:

Year:  2018        PMID: 30205195     DOI: 10.1016/j.tmaid.2018.08.007

Source DB:  PubMed          Journal:  Travel Med Infect Dis        ISSN: 1477-8939            Impact factor:   6.211


  1 in total

1.  ZikaPLAN: addressing the knowledge gaps and working towards a research preparedness network in the Americas.

Authors:  Annelies Wilder-Smith; Raman Preet; Elizabeth B Brickley; Ricardo Arraes de Alencar Ximenes; Demócrito de Barros Miranda-Filho; Celina Maria Turchi Martelli; Thália Velho Barreto de Araújo; Ulisses Ramos Montarroyos; Maria Elisabeth Moreira; Marília Dalva Turchi; Tom Solomon; Bart C Jacobs; Carlos Pardo Villamizar; Lyda Osorio; Ana Maria Bispo de Filipps; Johan Neyts; Suzanne Kaptein; Ralph Huits; Kevin K Ariën; Hugh J Willison; Julia M Edgar; Susan C Barnett; Rosanna Peeling; Debi Boeras; Maria G Guzman; Aravinda M de Silva; Andrew K Falconar; Claudia Romero-Vivas; Michael W Gaunt; Alessandro Sette; Daniela Weiskopf; Louis Lambrechts; Helen Dolk; Joan K Morris; Ieda M Orioli; Kathleen M O'Reilly; Laith Yakob; Joacim Rocklöv; Cristiane Soares; Maria Lúcia Brito Ferreira; Rafael Freitas de Oliveira Franca; Alexander R Precioso; James Logan; Trudie Lang; Nina Jamieson; Eduardo Massad
Journal:  Glob Health Action       Date:  2019       Impact factor: 2.640

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.